Cargando…
Thrombin Generation Biomarkers Decline With Parenteral Anticoagulation—An Overlooked Means of Anticoagulation Monitoring?
Anticoagulation therapy is administered to patients to prevent or stop thrombin generation in vivo. Although plasma tests of in vivo thrombin generation have been available for more than 2 decades, they are not routinely used in clinical trials or practice to monitor anticoagulation therapy. We obse...
Autores principales: | McFarland, Craig P., Lind, Stuart E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714868/ https://www.ncbi.nlm.nih.gov/pubmed/29439639 http://dx.doi.org/10.1177/1076029617746506 |
Ejemplares similares
-
Anticoagulants and the Propagation Phase of Thrombin Generation
por: Orfeo, Thomas, et al.
Publicado: (2011) -
Exploring potential anticoagulant drug formulations using thrombin generation test
por: Zavyalova, Elena, et al.
Publicado: (2015) -
Comparison is not reason: Pitfalls in reporting thrombin generation results in anticoagulated patients
por: Douxfils, Jonathan, et al.
Publicado: (2021) -
Kallikrein augments the anticoagulant function of the protein C system in thrombin generation
por: Wan, Jun, et al.
Publicado: (2021) -
Comparative Anticoagulant and Thrombin Generation Inhibitory Profile
of Heparin, Sulodexide and Its Components
por: Siddiqui, Fakiha, et al.
Publicado: (2020)